GH Research (GHRS) Exchange Rate Effect (2020 - 2025)
GH Research (GHRS) recorded quarterly Exchange Rate Effect of $155000.0 in Q4 2025, up 346.03% quarter-over-quarter from -$63000.0 in Q3 2025, and up 107.99% on a YoY basis from $74524.4 in Q4 2024.
GH Research (GHRS) Exchange Rate Effect (2020 - 2025) Analysis & Trends
GH Research's Exchange Rate Effect history runs 6 years deep, the most recent figure standing at $155000.0 for Q4 2025.
- In Q4 2025, Exchange Rate Effect rose 107.99% year-over-year to $155000.0; the TTM figure through Dec 2025 stood at $1.1 million (up 152.63% YoY), while the FY2025 annual figure was $3.2 million, up 255.26% from the prior year.
- Exchange Rate Effect was $155000.0 for Q4 2025 at GH Research, up from -$63000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $15.8 million in Q4 2022 to a low of -$7.1 million in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$55800.0 across 5 years, with a median of -$132500.0 in 2021.
- Biggest YoY gain for Exchange Rate Effect was 1489.57% in 2021; the steepest drop was 19066.67% in 2021.
- A 5-year view of Exchange Rate Effect shows it stood at $3.4 million in 2021, then jumped by 372.42% to $15.8 million in 2022, then plunged by 99.17% to $131000.0 in 2023, then plunged by 1581.68% to -$1.9 million in 2024, then jumped by 107.99% to $155000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $155000.0 (Q4 2025), -$63000.0 (Q3 2025), and $457000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 8.68 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 155,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 155,000.00 |
| Dec 31, 2025 | 155,000.00 |
| Sep 30, 2025 | -63,000.00 |
| Sep 30, 2025 | -63,000.00 |
| Jun 30, 2025 | 457,000.00 |
| Jun 30, 2025 | 457,000.00 |
| Mar 31, 2025 | 532,000.00 |
| Mar 31, 2025 | 532,000.00 |
| Dec 31, 2024 | -1.94 Mn |
| Dec 31, 2024 | -1.94 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | -446,000.00 |
| Jun 30, 2024 | -446,000.00 |
| Mar 31, 2024 | -1.29 Mn |
| Mar 31, 2024 | -1.29 Mn |
| Dec 31, 2023 | 131,000.00 |
| Dec 31, 2023 | 131,000.00 |
| Sep 30, 2023 | -1.78 Mn |
| Sep 30, 2023 | -1.78 Mn |